Elicia Penuel - Senior scientist, OBD/ Late stage biomarker development

Elicia Penuel

Senior scientist, OBD/ Late stage biomarker development

7
Years at Genentech
15
Publications

I (re)joined Genentech in 2010 to work on biomarkers in oncology. It was becoming clear that diagnostic markers of disease biology were critical for developing targeted therapeutics. Genentech was on the forefront of these scientific endeavours and was and continues to put significant effort and resources for research to identify predictive biomarkers.

This was a return for me having previously worked as a post-doctoral fellow at Genentech years earlier. It was no surprise when I returned to the same cooperative, creative and highly driven scientific expertise that I had already witnessed.

Featured Publication

HGF as a circulating biomarker of onartuzumab treatment in patients with advanced solid tumors.

Mol Cancer Ther. 2013 Jun;12(6):1122-30.

Penuel E, Li C, Parab V, Burton L, Cowan KJ, Merchant M, Yauch RL, Patel P, Peterson A, Hampton GM, Lackner MR, Hegde PS.